Peter de Waele
Algemeen Directeur bij Advanced Therapies Consulting Limited
Profiel
Peter de Waele is the founder of Xcellentis NV, which was founded in 2001, where he held the title of Chief Operating Officer in 2006.
He is currently the Managing Director at Advanced Therapies Consulting Limited.
Dr. de Waele's former positions include Chief Therapeutics Officer at Fujirebio Europe NV, Assistant Professor at Ghent University in 1986, and Vice President-Research & Development at Celyad Oncology SA from 2010 to 2017.
Dr. de Waele received his graduate and doctorate degrees from Ghent University.
Actieve functies van Peter de Waele
Bedrijven | Functie | Begin |
---|---|---|
Advanced Therapies Consulting Limited | Algemeen Directeur | - |
Eerdere bekende functies van Peter de Waele
Bedrijven | Functie | Einde |
---|---|---|
CELYAD ONCOLOGY SA | Hoofd Techniek/Wetenschap/O&O | - |
Xcellentis NV | Oprichter | 01-01-2006 |
Ghent University | Corporate Officer/Principal | 01-01-1986 |
Fujirebio Europe NV
Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Corporate Officer/Principal | - |
Opleiding van Peter de Waele
Ghent University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
CELYAD ONCOLOGY SA | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Xcellentis NV | Health Technology |
Fujirebio Europe NV
Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Health Technology |
Advanced Therapies Consulting Limited |